Being female or less affluent still linked to early death in cystic fibrosis

Despite improvements in survival for people with cystic fibrosis over the last 50 years, females and individuals from socioeconomically disadvantaged backgrounds continue to die younger than males and the more privileged in society, finds a study published in the British Medical Journal today.

The findings suggest that the socioeconomic and in age at death from first reported in 1989 persist to the present day.

Over the last 50 years, survival in individuals with cystic fibrosis has improved dramatically with the average age of death rising from six months in 1959 to 27 years in 2008, largely due to better health care provision. Around 20 years ago, it was shown that age at death was higher among men and those from socioeconomically advantaged backgrounds.

But is this still the case?

A team of researchers based at the University of Nottingham decided to test the theory that improved healthcare provision has led to a decline in these socioeconomic and sex differences. They analysed all registered deaths from cystic fibrosis in England and Wales from 1959 to 2008.

Between 1959 and 2008, the median age at death increased from age band 0-4 years to age band 25-29 years, and from the mid 1970s onwards tended to be higher in males than .

After adjusting for socioeconomic status, males were more likely to die above the median age than females in the 1970s and 1980s. Median age at death was also significantly higher in males compared with females between 2000 and 2008.

Between 1959 and 2000, median age at death was higher in the 'non manual' occupation group compared with the 'manual' group. Between 2001 and 2008, median age at death also tended to be higher in the 'professional and managerial' group compared with the 'routine and manual' group.

" should be aware that females and are associated with poorer outcomes than males and high socioeconomic status," conclude the authors. They suggest that environmental factors or varying access to healthcare might account for some of these differences.

In an accompanying editorial, experts say that the early appearance and persistence of inequalities support the need for early interventions and reinforce the importance of screening for cystic fibrosis in newborns.

One obvious target for action, they say, is to protect newly diagnosed children from environmental tobacco smoke, while future research should investigate and put into practice the most effective ways to reduce the socioeconomic gradient in health.

add to favorites email to friend print save as pdf

Related Stories

Is a good man still hard to find?

Feb 11, 2010

(PhysOrg.com) -- On Valentine’s Day couples make a special effort to celebrate their relationships. But spare a thought for the so-called ‘desperate and dateless’ - those people who would like to have ...

Recommended for you

Sensors may keep hospitalized patients from falling

1 hour ago

(Medical Xpress)—To keep hospitalized patients safer, University of Arizona researchers are working on new technology that involves a small, wearable sensor that measures a patient's activity, heart rate, ...

Rising role seen for health education specialists

3 hours ago

(HealthDay)—A health education specialist can help family practices implement quality improvement projects with limited additional financial resources, according to an article published in the March/April ...

FDA proposes first regulations for e-cigarettes

3 hours ago

The federal government wants to prohibit sales of electronic cigarettes to minors and require approval for new products and health warning labels under regulations being proposed by the Food and Drug Administration.

User comments